Compass Wealth Management LLC grew its holdings in Danaher Co. (NYSE:DHR – Free Report) by 30.4% during the 4th quarter, Holdings Channel reports. The firm owned 33,873 shares of the conglomerate’s stock after buying an additional 7,900 shares during the period. Danaher comprises approximately 1.9% of Compass Wealth Management LLC’s investment portfolio, making the stock its 8th biggest holding. Compass Wealth Management LLC’s holdings in Danaher were worth $7,776,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently bought and sold shares of DHR. Coronation Fund Managers Ltd. increased its position in Danaher by 29.9% during the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock worth $1,596,000 after purchasing an additional 1,470 shares during the last quarter. Public Sector Pension Investment Board increased its holdings in shares of Danaher by 119.8% during the 2nd quarter. Public Sector Pension Investment Board now owns 19,503 shares of the conglomerate’s stock worth $4,873,000 after buying an additional 10,628 shares during the last quarter. MBB Public Markets I LLC raised its position in shares of Danaher by 2,224.7% in the 2nd quarter. MBB Public Markets I LLC now owns 49,887 shares of the conglomerate’s stock worth $12,464,000 after buying an additional 47,741 shares during the period. Legal & General Group Plc boosted its holdings in Danaher by 2.4% in the second quarter. Legal & General Group Plc now owns 5,964,031 shares of the conglomerate’s stock valued at $1,490,112,000 after acquiring an additional 139,989 shares during the last quarter. Finally, Select Equity Group L.P. grew its position in Danaher by 5.5% during the second quarter. Select Equity Group L.P. now owns 402,017 shares of the conglomerate’s stock valued at $100,444,000 after acquiring an additional 21,023 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on DHR. Stifel Nicolaus boosted their target price on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. Robert W. Baird cut their target price on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Raymond James decreased their price target on shares of Danaher from $300.00 to $275.00 and set an “outperform” rating for the company in a research report on Tuesday. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Finally, Scotiabank initiated coverage on shares of Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price on the stock. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $285.55.
Danaher Stock Performance
Shares of DHR stock opened at $245.95 on Friday. The business has a 50 day simple moving average of $235.33 and a 200 day simple moving average of $253.45. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The firm has a market capitalization of $177.65 billion, a price-to-earnings ratio of 46.94, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83. Danaher Co. has a 12-month low of $225.42 and a 12-month high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period last year, the company earned $2.02 earnings per share. On average, equities research analysts anticipate that Danaher Co. will post 7.5 EPS for the current year.
Danaher Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be given a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s dividend payout ratio (DPR) is 20.61%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
- Five stocks we like better than Danaher
- Comparing and Trading High PE Ratio Stocks
- Bloom Energy: Powering the Future With Decentralized Energy
- What Are the U.K. Market Holidays? How to Invest and Trade
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.